← Leaderboards
Leonard Neckers
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsCellsMediatingNeoplastic CellComplexMolecular ChaperonesRenal CarcinomaClientIn VivoHeat-Shock Proteins 90Inhibitor/AntagonistTumorCancer CellPost-Translational Protein ProcessingAffectPhosphorylationMitochondriaNormal CellPhosphotransferasesMalignant NeoplasmsSiteBaseDependenceCell Proliferation
Grant awards (51)
HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction$872,254
ZIA · FY2025 · CA · contact PI
Post-translational modifications of Hsp90$872,254
ZIA · FY2025 · CA · contact PI
HSP90 and HSP70 Chaperone Proteins and Interactors in Cellular Signal Transduction$904,298
ZIA · FY2024 · CA · contact PI
Post-translational modifications of Hsp90$678,223
ZIA · FY2024 · CA · contact PI
Role of fumarate hydratase loss in development of HLRCC hereditary kidney cancer$678,223
ZIA · FY2024 · CA · contact PI
HSP90 and HSP7Chaperone Proteins and Interactors in Cellular Signal Transduction$897,836
ZIA · FY2023 · CA · contact PI
Post-translational modifications of Hsp90$673,377
ZIA · FY2023 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$673,377
ZIA · FY2023 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$866,305
ZIA · FY2022 · CA · contact PI
HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction$866,305
ZIA · FY2022 · CA · contact PI
Post-translational modifications of Hsp90$433,153
ZIA · FY2022 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$824,045
ZIA · FY2021 · CA · contact PI
HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction$824,045
ZIA · FY2021 · CA · contact PI
Post-translational modifications of Hsp90$412,022
ZIA · FY2021 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$790,301
ZIA · FY2020 · CA · contact PI
HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction$790,301
ZIA · FY2020 · CA · contact PI
Post-translational modifications of Hsp90$395,150
ZIA · FY2020 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$761,487
ZIA · FY2019 · CA · contact PI
Post-translational modifications of Hsp90$761,487
ZIA · FY2019 · CA · contact PI
HSP90 Chaperone Proteins and Interactors in Cellular Signal Transduction$652,703
ZIA · FY2019 · CA · contact PI
HSP90 Chaperone Proteins Chaperone Interactors in Cellular Signal Transduction$875,210
ZIA · FY2018 · CA · contact PI
Post-translational modifications of Hsp90$656,408
ZIA · FY2018 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$656,408
ZIA · FY2018 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$913,077
ZIA · FY2017 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$913,077
ZIA · FY2017 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$456,538
ZIA · FY2017 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$789,092
ZIA · FY2016 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$789,092
ZIA · FY2016 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$394,547
ZIA · FY2016 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$929,509
ZIA · FY2015 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$929,509
ZIA · FY2015 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$464,754
ZIA · FY2015 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$668,014
ZIA · FY2014 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$668,014
ZIA · FY2014 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$334,007
ZIA · FY2014 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$618,976
ZIA · FY2013 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$618,976
ZIA · FY2013 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$309,488
ZIA · FY2013 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$694,020
ZIA · FY2012 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$694,020
ZIA · FY2012 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$347,009
ZIA · FY2012 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$688,740
ZIA · FY2011 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$688,740
ZIA · FY2011 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$344,370
ZIA · FY2011 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$672,998
ZIA · FY2010 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$672,998
ZIA · FY2010 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$336,500
ZIA · FY2010 · CA · contact PI
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction$650,522
ZIA · FY2009 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$650,522
ZIA · FY2009 · CA · contact PI
Role of FH loss in development of HLRCC heriditary kidney cancer$325,260
ZIA · FY2009 · CA · contact PI
Post-translational modifications of Hsp90 that impact drug efficacy$663,995
Z01 · FY2008 · CA · contact PI